Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xencor (XNCR) Asset Writedowns and Impairment (2017 - 2025)

Xencor (XNCR) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with -$8.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 54.21% to -$8.3 million in Q4 2025 year-over-year; TTM through Sep 2025 was -$9.8 million, a 149.98% decrease, with the full-year FY2024 number at $2.3 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment was -$8.3 million for Q4 2025 at Xencor, down from $1.6 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $20.6 million in Q1 2024 to a low of -$18.1 million in Q4 2024.
  • A 5-year average of $249421.1 and a median of $273000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 6333.02% in 2024; the steepest drop was 2171.14% in 2024.
  • Xencor's Asset Writedowns and Impairment stood at $173000.0 in 2021, then rose by 3.47% to $179000.0 in 2022, then plummeted by 545.25% to -$797000.0 in 2023, then plummeted by 2171.14% to -$18.1 million in 2024, then surged by 54.21% to -$8.3 million in 2025.
  • Per Business Quant, the three most recent readings for XNCR's Asset Writedowns and Impairment are -$8.3 million (Q4 2025), $1.6 million (Q3 2025), and $1.9 million (Q2 2025).